EVER Pharma Jena GmbH (manufacturing of medicinal product, responsible for batch control and batch release; alternative unit for secondary packaging)

The drug is prescribed to women in the postmenopausal period for the treatment of estrogen receptor-positive locally advanced or metastatic breast cancer. It may be used either as monotherapy or in combination with palbociclib.

Dosage form: solution for injection

ATC: L02BA03